VELMENI Secures FDA 510(k) Clearance for AI-Powered 3D CBCT Dental Imaging Software ‘VELMENI for DENTISTS (V4D) 3D,’ Expanding Dental AI Portfolio

July 26, 2026

PR Newswire USA

Overview

VELMENI announced that its AI-powered 3D Cone Beam Computed Tomography (CBCT) dental imaging software, ‘VELMENI for DENTISTS (V4D) 3D,’ has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This approval significantly expands VELMENI’s dental AI solution portfolio from 2D to 3D image analysis, promising enhanced accuracy and efficiency in dental diagnostics. V4D 3D aims to assist dentists in developing more precise treatment plans and elevating the quality of patient care.

In Depth

Key Findings

VELMENI has announced that its AI-powered 3D Cone Beam Computed Tomography (CBCT) dental imaging software, ‘VELMENI for DENTISTS (V4D) 3D,’ has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This significant approval marks a pivotal expansion of VELMENI’s dental AI solution portfolio from two-dimensional (2D) to three-dimensional (3D) image analysis, representing a major leap in AI application within the dental healthcare sector.

Technical & Clinical Details

Advanced 3D CBCT Image Analysis: V4D 3D utilizes sophisticated AI algorithms to analyze high-resolution 3D data acquired from dental CBCT scans. This capability allows for a comprehensive, volumetric understanding of complex oral structures, including bone morphology, root canal anatomy, and precise lesion localization, which are often challenging to assess with traditional 2D radiographic images.
Improved Diagnostic Accuracy and Treatment Planning: By automatically identifying anomalous regions and critical anatomical structures, the AI assists dental practitioners in making faster and more accurate diagnoses. This enables optimal treatment planning for intricate procedures such as implant placements, orthodontic treatments, and endodontic interventions. The enhanced precision directly translates to improved patient safety and better clinical outcomes.
Streamlined Workflow Efficiency: The software’s automated analytical capabilities streamline the diagnostic process, reducing the time commitment and workload for dentists and their staff. This efficiency gain allows for greater patient throughput and improved access to advanced dental care.

Background & Industry Context

In dentistry, accurately interpreting the intricate oral anatomy is paramount for successful diagnosis and treatment. While CBCT technology offers high-definition 3D imaging with reduced radiation exposure, the efficient analysis of vast datasets requires specialized skills and considerable time. The integration of AI technology addresses this challenge by providing a powerful tool that augments the diagnostic capabilities of dental professionals. The FDA clearance validates V4D 3D’s safety and efficacy, further accelerating the growth and adoption of AI in the dental market.

Future Outlook

The FDA clearance for VELMENI for DENTISTS (V4D) 3D opens substantial market opportunities for VELMENI in the United States. The company plans to leverage this product as a cornerstone to further expand its portfolio of dental AI solutions and drive digital transformation across global dental healthcare. Anticipated future developments include AI playing an indispensable role in broader dental services, such as preventive dentistry, early intervention strategies, and patient education initiatives.

Source: https://www.prnewswire.com/news-releases/velmeni-receives-fda-510k-clearance-for-ai-powered-3d-cbct-dental-imaging-software-302833735.html

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.